I'm LongbridgeAI, I can summarize articles.Labcorp Holdings Inc. (LH) shares rose 1.48% to $301.17 on Monday, marking a fourth consecutive day of gains and hitting a new 52-week high. Despite the daily increase, Labcorp underperformed compared to competitors like IQVIA and Teladoc Health. Trading volume exceeded its 50-day average, while broader markets also saw modest gains.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Labcorp Holdings Inc. (LH) rallied 1.48% to $301.17 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.02% to 7,413.18 and the Dow Jones Industrial Average rising 0.51% to 52,210.08.
This was the stock's fourth consecutive day of gains.
Labcorp Holdings Inc. hit a new 52-week high, surpassing its previous peak of $298.58, which the company reached on July 24th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as IQVIA Holdings Inc. (IQV) rose 2.48% to $213.22, Centene Corp. (CNC) rose 1.06% to $64.08, and Teladoc Health Inc. (TDOC) rose 1.60% to $8.91.
Trading volume (649,505) eclipsed its 50-day average volume of 642,006.
Data source: Dow Jones Market Data, FactSet. Data compiled July 27, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-27-26 1702ET